CYTRELLIS BIOSYSTEMS
Cytrellis Biosystems is a clinical stage medical technology company that designs and develops medical device for dermatology, scar reduction, and aesthetic medicine. Its devices are designed to remove sagging skin associated with aging without surgery or scarring, providing aesthetic practitioners an unprecedented ability to improve age related changes in skin. Cytrellis Biosystems was founded in 2011 and is based in Boston, Massachusetts.
CYTRELLIS BIOSYSTEMS
Industry:
Biotechnology Health Care Medical
Founded:
2012-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.cytrellis.com
Total Employee:
11+
Status:
Active
Contact:
+1 857 254 1725
Email Addresses:
[email protected]
Total Funding:
86.09 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt WordPress Google Universal Analytics Wordpress Plugins
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Current Advisors List
Current Employees Featured
Founder
Investors List
PFM Health Sciences
PFM Health Sciences investment in Series C - Cytrellis Biosystems
D1 Capital Partners
D1 Capital Partners investment in Series C - Cytrellis Biosystems
ARCH Venture Partners
ARCH Venture Partners investment in Series C - Cytrellis Biosystems
Sands Capital Ventures
Sands Capital Ventures investment in Series C - Cytrellis Biosystems
Biomatics Capital Partners
Biomatics Capital Partners investment in Series B - Cytrellis Biosystems
ARCH Venture Partners
ARCH Venture Partners investment in Series B - Cytrellis Biosystems
Merz Venture Initiative
Merz Venture Initiative investment in Series B - Cytrellis Biosystems
Partner Fund Management
Partner Fund Management investment in Series B - Cytrellis Biosystems
ARCH Venture Partners
ARCH Venture Partners investment in Series A - Cytrellis Biosystems
Official Site Inspections
http://www.cytrellis.com Semrush global rank: 7.12 M Semrush visits lastest month: 585
- Host name: 65.249.197.104.bc.googleusercontent.com
- IP address: 104.197.249.65
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Cytrellis Biosystems"
Cytrellis Biosystems - Crunchbase Company Profile
Cytrellis Biosystems is a clinical stage medical technology company that designs and develops medical device for dermatology, scar reduction, and aesthetic medicine. Its devices are designed to remove sagging skin associated with โฆSee details»
Cytrellis Biosystems, Inc. | LinkedIn
Cytrellis is a medical technology company dedicated to the development and commercialization of first-in-class aesthetic devices which emphasize safety, efficacy, and improved quality of life โฆSee details»
Cytrellis Company Profile 2024: Valuation, Funding & Investors
Nov 19, 2017 Cytrellis General Information Description. Developer of an aesthetic technology designed to eliminate skin-related problems without any surgery. The company's technology โฆSee details»
Director Regulatory and Quality Affairs ABOUT US - Cytrellis
Cytrellis is dedicated to working with leading physicians to develop unique product ... o Develop a right-sized quality organization and system that provides flexibility but assures compliance for โฆSee details»
Investors โ Cytrellis, Inc.
You are about to leave the Cytrellis site and be transferred to an independent medical portal. Cancel Redirect Now. Investors. Cytrellis is backed by leading venture capital investors in the โฆSee details»
Cytrellis Biosystems, Inc. Company Profile - Dun & Bradstreet
This information is updated and provided by Cytrellis Biosystems, Inc. The content available on the D&B Business Directory is provided "as-is" and "as-available" and may not be reviewed or โฆSee details»
Cytrellis Biosystems CEO and Key Executive Team | Craft.co
Cytrellis Biosystems's President & Chief Executive Officer is Jason Richey. Other executives include Doug Levinson, Founder; Jackson McAdam, Chief Financial Officer and 9 others. See โฆSee details»
Cytrellis Names News President and Chief Executive Officer
Jun 17, 2022 Cytrellis is a medical technology company dedicated to the development and commercialization of first-in-class aesthetic devices. "We are thrilled to welcome Jason to the โฆSee details»
Cytrellis Announces Jason Richey as President and Chief Executive โฆ
Jun 1, 2022 Cytrellis Biosystems, Inc. is a medical technology company whose first product, the ellacor ® System with Micro-Coringโข Technology, is a novel class of aesthetic devices โฆSee details»
Cytrellis Biosystems - Craft
Cytrellis Biosystems, Inc. is a clinical stage medical technology company developing a proprietary new class of aesthetic devices. Our devices are designed to remove sagging skin associated โฆSee details»
Cytrellis Biosystems - Contacts, Employees, Board Members, โฆ
Organization. Cytrellis Biosystems . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... About. Cytrellis Biosystems has 3 current employee profiles, โฆSee details»
Cytrellis Biosystems - Funding, Financials, Valuation & Investors
Cytrellis Biosystems is funded by 7 investors. PFM Health Sciences and D1 Capital Partners are the most recent investors. Cytrellis Biosystems has a post-money valuation in the range of โฆSee details»
Cytrellis Biosystems Completes $50 Million Series C Financing
Sep 21, 2021 Cytrellis is dedicated to working with leading dermatologists and plastic surgeons to develop unique product solutions which emphasize safety, clinical results and improved โฆSee details»
First-in-Class Technology โ Cytrellis, Inc.
Each patient heals differently; mild to moderate side effects may still be present up to 30 days post-treatment per physician assessment. All clinical data, including patient healing, treatment โฆSee details»
Physician Home - ellacor®
Each patient heals differently; mild to moderate side effects may still be present up to 30 days post-treatment per physician assessment. All clinical data, including patient healing, treatment โฆSee details»
Our Vision โ Cytrellis, Inc.
The future starts here. From our inception, our vision was to create truly novel advancements in the aesthetics industry. Based on the pioneering work of leading dermatologists and plastic โฆSee details»
Why Cytrellis? | A History of Excellence - YouTube
Hear from Cytrellis CEO, Jason Richey as he dives into the backstory and DNA of the company, as well as its new ellacorโ Micro-Coringโ Technology that is set...See details»
Cytrellis Biosystems Completes $50 Million Series C Financing
Sep 21, 2021 Cytrellis is dedicated to innovation, and we are excited to help the company realize the potential of its clinical research and product development platform over the coming โฆSee details»